📰 Nasdaq Coll News
Page 2 - Nasdaq Coll News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.
December 21, 2023
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CEO Joseph Ciaffoni sold 14,516 shares of the company’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $30.03, for a total transaction of $435,915.48. Following the completion of the transaction, the chief executive officer now directly owns 275,000 […]
December 17, 2023
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Wednesday morning. Separately, Needham & Company LLC raised their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research report on Friday, August […]
December 16, 2023
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Needham & Company LLC increased their price objective on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research note on […]
December 9, 2023
StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday morning. Separately, Needham & Company LLC increased their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the company a buy rating in a research report on Friday, […]
November 17, 2023
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) saw a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 6,010,000 shares, a drop of 7.3% from the October 15th total of 6,480,000 shares. Approximately 17.8% of the shares of the company are short sold. Based […]
August 28, 2023
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 7,640,000 shares, a growth of 28.6% from the July 31st total of 5,940,000 shares. Currently, 22.6% of the company’s shares are sold short. […]
August 28, 2023
Collegium Pharmaceutical (NASDAQ:COLL – Free Report) had its price objective lifted by Needham & Company LLC from $35.00 to $36.00 in a report published on Friday morning, MarketBeat reports. Needham & Company LLC currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts have also recently weighed in […]
August 28, 2023
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 7,640,000 shares, an increase of 28.6% from the July 31st total of 5,940,000 shares. Approximately 22.6% of the shares of the company are […]
August 18, 2023
South Dakota Investment Council trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 11.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 248,972 shares of the specialty pharmaceutical company’s stock after selling 32,600 shares […]
August 16, 2023
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 5,940,000 shares, a drop of 9.6% from the July 15th total of 6,570,000 shares. Currently, 17.6% of the company’s stock are short sold. […]